Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Cerebromicrovascular dysfunction predicts cognitive decline and gait abnormalities in a mouse model of whole brain irradiation-induced accelerated brain senescence.

Ungvari Z, Tarantini S, Hertelendy P, Valcarcel-Ares MN, Fülöp GA, Logan S, Kiss T, Farkas E, Csiszar A, Yabluchanskiy A.

Geroscience. 2017 Feb;39(1):33-42. doi: 10.1007/s11357-017-9964-z.

2.

Methods and results of local treatment of brain metastases in patients with breast cancer.

Szadurska A, Pluta E, Walasek T, Blecharz P, Jakubowicz J, Mituś JW.

Contemp Oncol (Pozn). 2016;20(6):430-435. doi: 10.5114/wo.2016.65601. Review.

3.

TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin.

Moruno-Manchon JF, Uzor NE, Kesler SR, Wefel JS, Townley DM, Nagaraja AS, Pradeep S, Mangala LS, Sood AK, Tsvetkov AS.

Aging (Albany NY). 2016 Dec 16;8(12):3507-3519. doi: 10.18632/aging.101144.

4.

Effect of the Maximum Dose on White Matter Fiber Bundles Using Longitudinal Diffusion Tensor Imaging.

Zhu T, Chapman CH, Tsien C, Kim M, Spratt DE, Lawrence TS, Cao Y.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):696-705. doi: 10.1016/j.ijrobp.2016.07.010.

PMID:
27681767
5.

The role of whole brain radiation in primary CNS lymphoma.

Kasenda B, Loeffler J, Illerhaus G, Ferreri AJ, Rubenstein J, Batchelor TT.

Blood. 2016 Jul 7;128(1):32-6. doi: 10.1182/blood-2016-01-650101. Review. No abstract available.

PMID:
27207798
6.

Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons.

Manchon JF, Dabaghian Y, Uzor NE, Kesler SR, Wefel JS, Tsvetkov AS.

Sci Rep. 2016 May 11;6:25705. doi: 10.1038/srep25705.

7.

Patient-reported versus objectively-measured physical function and mortality risk among cancer survivors.

Brown JC, Harhay MO, Harhay MN.

J Geriatr Oncol. 2016 Mar;7(2):108-15. doi: 10.1016/j.jgo.2016.01.009.

8.

EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.

Durand T, Jacob S, Lebouil L, Douzane H, Lestaevel P, Rahimian A, Psimaras D, Feuvret L, Leclercq D, Brochet B, Tamarat R, Milliat F, Benderitter M, Vayatis N, Noël G, Hoang-Xuan K, Delattre JY, Ricard D, Bernier MO.

BMC Neurol. 2015 Dec 18;15:261. doi: 10.1186/s12883-015-0519-6.

9.

Analysis of risk and predictors of brain radiation necrosis after radiosurgery.

Zhuang H, Zheng Y, Wang J, Chang JY, Wang X, Yuan Z, Wang P.

Oncotarget. 2016 Feb 16;7(7):7773-9. doi: 10.18632/oncotarget.6532.

10.

Long-term Toxicity of Cancer Treatment in Older Patients.

Shahrokni A, Wu AJ, Carter J, Lichtman SM.

Clin Geriatr Med. 2016 Feb;32(1):63-80. doi: 10.1016/j.cger.2015.08.005. Review.

11.

Treatment of Retinoblastoma: The Role of External Beam Radiotherapy.

Kim JY, Park Y.

Yonsei Med J. 2015 Nov;56(6):1478-91. doi: 10.3349/ymj.2015.56.6.1478. Review.

12.

Potential toxicities of prophylactic cranial irradiation.

Giordano FA, Welzel G, Abo-Madyan Y, Wenz F.

Transl Lung Cancer Res. 2012 Dec;1(4):254-62. doi: 10.3978/j.issn.2218-6751.2012.10.03. Review.

13.

Pros and cons of current brain tumor imaging.

Ellingson BM, Wen PY, van den Bent MJ, Cloughesy TF.

Neuro Oncol. 2014 Oct;16 Suppl 7:vii2-11. doi: 10.1093/neuonc/nou224. Review.

14.

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

Castellino SM, Ullrich NJ, Whelen MJ, Lange BJ.

J Natl Cancer Inst. 2014 Jul 30;106(8). pii: dju186. doi: 10.1093/jnci/dju186. Review.

15.

Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases.

Schüttrumpf LH, Niyazi M, Nachbichler SB, Manapov F, Jansen N, Siefert A, Belka C.

Radiat Oncol. 2014 May 2;9:105. doi: 10.1186/1748-717X-9-105.

16.

Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy.

Shibayama O, Yoshiuchi K, Inagaki M, Matsuoka Y, Yoshikawa E, Sugawara Y, Akechi T, Wada N, Imoto S, Murakami K, Ogawa A, Akabayashi A, Uchitomi Y.

Cancer Med. 2014 Jun;3(3):702-9. doi: 10.1002/cam4.174.

17.

Cognitive and neuropsychiatric impairment in cerebral radionecrosis patients after radiotherapy of nasopharyngeal carcinoma.

Wu X, Gu M, Zhou G, Xu X, Wu M, Huang H.

BMC Neurol. 2014 Jan 13;14:10. doi: 10.1186/1471-2377-14-10.

18.

Radiation and concomitant chemotherapy for patients with glioblastoma multiforme.

Villà S, Balañà C, Comas S.

Chin J Cancer. 2014 Jan;33(1):25-31. doi: 10.5732/cjc.013.10216. Review.

19.

Cisplatin inhibits hippocampal cell proliferation and alters the expression of apoptotic genes.

Manohar S, Jamesdaniel S, Salvi R.

Neurotox Res. 2014 May;25(4):369-80. doi: 10.1007/s12640-013-9443-y.

20.

New challenges in high-energy particle radiobiology.

Durante M.

Br J Radiol. 2014 Mar;87(1035):20130626. doi: 10.1259/bjr.20130626. Review.

Supplemental Content

Support Center